Table 1Outcome assessmentLevelOutcomesMeasurement**Primary**WBC, CRP, IL-6, TNF-α, IFN-G ESRLaboratory blood testIntensity of pulmonary involvementCT scanMortality rateObservation**Secondary**BMIAccording to weight and heightDuration of hospitalizationObservationSaturation percentage of blood oxygenPulse oximeter
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